PATENT CLAIM ANALYSIS

Application Number: 16087223
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "016500"]

Abstract:
Disclosed are CD31 shed  agonists for use in the prevention and/or treatment of reperfusion injury. These CD31 shed  agonists are peptides or peptidomimetics thereof that are able to restore CD31 signaling in cells bearing a truncated form of CD31 called CD31 shed . The CD31 shed  agonists particularly protect from organ damages caused by reperfusion used to treat ischemia.

Claim (Index 25):
The method according to claim  1 , wherein said CD31 shed  agonist is administered intravenously.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.4186
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14809603', '13001513', '12645991', '11901939', '13782881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7996879261135724
- 35 USC 102 Novelty (BERT): 0.5243324202687798
- Combined Prediction Score: 0.7721523755290931
- Mean Citation Score: 325.796382
- Max Citation Score: 339.41687
- Similarity Product: 269.91558052098753

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test